Logo image of MARP.MI

MARZOCCHI POMPE SPA (MARP.MI) Stock Fundamental Analysis

BIT:MARP - Euronext Milan - IT0004376858 - Common Stock - Currency: EUR

2.8  -0.08 (-2.78%)

Fundamental Rating

3

Overall MARP gets a fundamental rating of 3 out of 10. We evaluated MARP against 107 industry peers in the Machinery industry. Both the profitability and the financial health of MARP get a neutral evaluation. Nothing too spectacular is happening here. MARP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year MARP was profitable.
MARP had a positive operating cash flow in the past year.
MARP had positive earnings in each of the past 5 years.
In the past 5 years MARP always reported a positive cash flow from operatings.
MARP.MI Yearly Net Income VS EBIT VS OCF VS FCFMARP.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

The Return On Assets of MARP (0.69%) is worse than 63.55% of its industry peers.
Looking at the Return On Equity, with a value of 1.51%, MARP is doing worse than 66.36% of the companies in the same industry.
MARP has a Return On Invested Capital of 2.43%. This is in the lower half of the industry: MARP underperforms 71.96% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MARP is below the industry average of 9.11%.
The 3 year average ROIC (6.66%) for MARP is well above the current ROIC(2.43%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.69%
ROE 1.51%
ROIC 2.43%
ROA(3y)3.35%
ROA(5y)2.77%
ROE(3y)7.93%
ROE(5y)6.61%
ROIC(3y)6.66%
ROIC(5y)N/A
MARP.MI Yearly ROA, ROE, ROICMARP.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

The Profit Margin of MARP (0.82%) is worse than 64.49% of its industry peers.
In the last couple of years the Profit Margin of MARP has grown nicely.
MARP has a worse Operating Margin (2.32%) than 73.83% of its industry peers.
In the last couple of years the Operating Margin of MARP has declined.
MARP's Gross Margin of 47.37% is fine compared to the rest of the industry. MARP outperforms 62.62% of its industry peers.
In the last couple of years the Gross Margin of MARP has remained more or less at the same level.
Industry RankSector Rank
OM 2.32%
PM (TTM) 0.82%
GM 47.37%
OM growth 3Y-25.57%
OM growth 5Y-1.68%
PM growth 3Y-40.58%
PM growth 5Y10.48%
GM growth 3Y-2.81%
GM growth 5Y-0.68%
MARP.MI Yearly Profit, Operating, Gross MarginsMARP.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

5

2. Health

2.1 Basic Checks

MARP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MARP has been reduced compared to 1 year ago.
Compared to 5 years ago, MARP has less shares outstanding
MARP has a better debt/assets ratio than last year.
MARP.MI Yearly Shares OutstandingMARP.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
MARP.MI Yearly Total Debt VS Total AssetsMARP.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

MARP has an Altman-Z score of 2.05. This is not the best score and indicates that MARP is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.05, MARP is in line with its industry, outperforming 46.73% of the companies in the same industry.
MARP has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.12, MARP is doing good in the industry, outperforming 79.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 2.05
ROIC/WACC0.34
WACC7.14%
MARP.MI Yearly LT Debt VS Equity VS FCFMARP.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

MARP has a Current Ratio of 1.77. This is a normal value and indicates that MARP is financially healthy and should not expect problems in meeting its short term obligations.
MARP's Current ratio of 1.77 is fine compared to the rest of the industry. MARP outperforms 64.49% of its industry peers.
MARP has a Quick Ratio of 1.19. This is a normal value and indicates that MARP is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MARP (1.19) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.19
MARP.MI Yearly Current Assets VS Current LiabilitesMARP.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for MARP have decreased strongly by -89.14% in the last year.
Measured over the past years, MARP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.15% on average per year.
The Revenue for MARP has decreased by -19.51% in the past year. This is quite bad
The Revenue has been growing slightly by 0.01% on average over the past years.
EPS 1Y (TTM)-89.14%
EPS 3Y-40.36%
EPS 5Y11.15%
EPS Q2Q%-210.2%
Revenue 1Y (TTM)-19.51%
Revenue growth 3Y-0.41%
Revenue growth 5Y0.01%
Sales Q2Q%-22.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MARP.MI Yearly Revenue VS EstimatesMARP.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MARP.MI Yearly EPS VS EstimatesMARP.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.1 0.2 0.3 0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MARP is valuated quite expensively with a Price/Earnings ratio of 56.00.
MARP's Price/Earnings ratio is a bit more expensive when compared to the industry. MARP is more expensive than 65.42% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.65. MARP is valued rather expensively when compared to this.
Industry RankSector Rank
PE 56
Fwd PE N/A
MARP.MI Price Earnings VS Forward Price EarningsMARP.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MARP.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.48
MARP.MI Per share dataMARP.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)5.02
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.14%, MARP is a good candidate for dividend investing.
In the last 3 months the price of MARP has falen by -32.04%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
MARP's Dividend Yield is rather good when compared to the industry average which is at 2.47. MARP pays more dividend than 100.00% of the companies in the same industry.
MARP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 7.14%

5.2 History

The dividend of MARP is nicely growing with an annual growth rate of 35.72%!
Dividend Growth(5Y)35.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

393.87% of the earnings are spent on dividend by MARP. This is not a sustainable payout ratio.
The dividend of MARP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP393.87%
EPS Next 2YN/A
EPS Next 3YN/A
MARP.MI Yearly Income VS Free CF VS DividendMARP.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M
MARP.MI Dividend Payout.MARP.MI Dividend Payout, showing the Payout Ratio.MARP.MI Dividend Payout.PayoutRetained Earnings

More info and screens

MARZOCCHI POMPE SPA

BIT:MARP (6/23/2025, 7:00:00 PM)

2.8

-0.08 (-2.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.45%
Inst Owner ChangeN/A
Ins Owners4.7%
Ins Owner ChangeN/A
Market Cap18.31M
Analysts82.86
Price Target8.67 (209.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.14%
Yearly Dividend0.2
Dividend Growth(5Y)35.72%
DP393.87%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 56
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF 16.38
P/B 0.84
P/tB 0.86
EV/EBITDA 8.48
EPS(TTM)0.05
EY1.79%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)0.17
OCFY6.1%
SpS6.12
BVpS3.35
TBVpS3.26
PEG (NY)N/A
PEG (5Y)5.02
Profitability
Industry RankSector Rank
ROA 0.69%
ROE 1.51%
ROCE 3%
ROIC 2.43%
ROICexc 2.86%
ROICexgc 2.93%
OM 2.32%
PM (TTM) 0.82%
GM 47.37%
FCFM N/A
ROA(3y)3.35%
ROA(5y)2.77%
ROE(3y)7.93%
ROE(5y)6.61%
ROIC(3y)6.66%
ROIC(5y)N/A
ROICexc(3y)9.43%
ROICexc(5y)N/A
ROICexgc(3y)9.81%
ROICexgc(5y)N/A
ROCE(3y)8.23%
ROCE(5y)N/A
ROICexcg growth 3Y-27.51%
ROICexcg growth 5Y-3.54%
ROICexc growth 3Y-26.77%
ROICexc growth 5Y-2.85%
OM growth 3Y-25.57%
OM growth 5Y-1.68%
PM growth 3Y-40.58%
PM growth 5Y10.48%
GM growth 3Y-2.81%
GM growth 5Y-0.68%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA 0.72
Cap/Depr 111.02%
Cap/Sales 7.28%
Interest Coverage 250
Cash Conversion 31.44%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.19
Altman-Z 2.05
F-Score5
WACC7.14%
ROIC/WACC0.34
Cap/Depr(3y)89.71%
Cap/Depr(5y)66.19%
Cap/Sales(3y)6.79%
Cap/Sales(5y)5.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.14%
EPS 3Y-40.36%
EPS 5Y11.15%
EPS Q2Q%-210.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.51%
Revenue growth 3Y-0.41%
Revenue growth 5Y0.01%
Sales Q2Q%-22.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-78.9%
EBIT growth 3Y-25.88%
EBIT growth 5Y-1.67%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-323.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-69.88%
OCF growth 3Y-29.86%
OCF growth 5Y-17.53%